JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis

Vasileia-Ismini Alexaki1, Delphine Javelaud, Alain Mauviel

  • 1INSERM U697 and Université Paris-Diderot, Paris, France.

Insights

Inhibiting JNK1/2 proteins in human melanoma cells halts growth by causing cell cycle arrest or apoptosis. JNK1 is crucial for melanoma cell proliferation, impacting cell cycle progression and survival.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • JNK1/2 proteins are stress-activated protein kinases regulating cell growth, survival, and death.
  • Their precise role in melanoma progression remains incompletely understood.
  • Melanoma cell lines exhibit varying responses to JNK pathway modulation.

Purpose of the Study:

  • To investigate the role of JNK1/2 in human melanoma cell growth and survival.
  • To determine the downstream mechanisms by which JNK inhibition affects melanoma cells.
  • To identify the specific JNK isoforms critical for melanoma cell proliferation.

Main Methods:

  • Utilized the small molecule inhibitor SP600125 to inhibit JNK1/2 activity.
  • Employed small interfering RNA (siRNA) for specific gene knockdown of JNK1 and JNK2.
  • Analyzed cell cycle progression (G2/M arrest), apoptosis, and protein expression (p53, p21 Cip1/Waf1, Bad, Bax).
  • Correlated effects with baseline phospho-JNK1 (P-JNK1) levels.

Main Results:

  • JNK inhibition induced G2/M cell cycle arrest or apoptosis, cell-line dependent.
  • In 1205Lu cells, JNK inhibition led to p53-dependent p21 Cip1/Waf1 induction and cell cycle arrest.
  • In WM983B cells, JNK inhibition induced apoptosis with p53, Bad, and Bax upregulation, but not p21 Cip1/Waf1.
  • SP600125 treatment and JNK1 knockdown significantly inhibited growth, particularly in cells with high P-JNK1 levels.
  • JNK2 knockdown had no effect on cell growth.

Conclusions:

  • JNK1/2 signaling supports human melanoma cell growth.
  • JNK1 is the predominant isoform driving melanoma cell proliferation.
  • JNK inhibition impacts melanoma cell fate through modulation of cell cycle progression or apoptosis, contingent on cellular context.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...